A History of Innovation
Passionate about Bionics
What We Do
Control Bionics offers a suite of dedicated speech generating devices and AAC accessories to give people living with complex communication and physical needs their voice. Our product range is more intuitive and flexible than ever, giving users the power to make life-changing connections.
Life Changing Connections
Control Bionics aim is to become the world’s leading provider of innovative augmentative communication and control devices for people with speech and movement disabilities. Our entry into the assistive technology industry is based on our passion to serve those on the far end of the disability spectrum and the desire to drive the industry forward.
Control Bionics is incorporated in the state of Delaware and the first international patents are filed.
James Schorey joined forces with Peter Ford and brings the intellectual property of Therapeutic Alliances (TAI). Control Bionics moves USA headquarters to Milford, Ohio, and significantly expands production and product development space and capabilities.
Control Bionics moves USA headquarters to Milford, Ohio, and significantly expands production and product development space and capabilities.
“Our mission is to develop accessible, leading-edge AAC devices that can help those living with paralysis and loss of speech gain more control over their world.”
Driving the Industry Forward
CEO AND MANAGING DIRECTOR
Jeremy has over 25 years of global corporate experience in a wide range of industries including healthcare, technology, financial services and retail. Jeremy has been both an investor and operator and most recently was Global CEO of CardioScan, and outsourced cardiac diagnostics business operating in 10 countries.
Jeremy has a Bachelor of Commerce from the University of Adelaide and was appointed to CEO and Managing Director of Control Bionics in early 2023.
Chief Technology Officer
James began his career at Therapeutic Technologies Inc. (TTI) as a software engineer. In ten years at TTI he rose through the ranks to become Director of Engineering, managing three FDA-registered Class II medical devices. He then went on to become the President of Therapeutic Alliances, a leader in the field of rehabilitation for paralyzed individuals.
In 2014 James joined the Control Bionics team and now serves as the Chief Technology Officer. He is the driving force behind the design and development of the NeuroNode and all of the Control Bionics product lines.
Vice President – North America
Todd Tyler is the Vice President – North America for Control Bionics. He holds a Master’s of Science Degree in Communication Sciences and Disorders from the University of Oklahoma. Todd has over 20 years of experience in healthcare including roles in Speech-Language Pathology, sales, marketing, business development and executive leadership. Todd believes in the power of communication to make life-changing connections.
Todd’s breadth of experience and professional background give him the ability to lead a collaborative and dynamic team. Todd is based in our North America office in Milford, Ohio.
Meagan Koeneman is director of Sales for Control Bionics. She directs all sales strategies, partners with organizations to grow product awareness, and leads field sales activities. After spending nearly a decade supporting people and families with disabilities, Meagan believes that the key to strong sales partnerships lies in the human connection. Being genuinely curious, empathetic, and customer-centric drives our conversations and creates the value at the heart of this team.
Meagan holds a BA in Speech & Hearing Sciences from Indiana University. She currently resides in Indianapolis, Indiana with her husband and 3 children.